Allergan S.A. DE C.V.. clinical trials
Acquired by AbbVie, May 8, 2020 · source ↗
The registry lists 1 studies whose lead sponsor is Allergan S.A. DE C.V... 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 30, 2012.
Before and after it joined AbbVie
- First submitted before Allergan S.A. DE C.V.. became part of AbbVie
- 1
- First submitted after Allergan S.A. DE C.V.. became part of AbbVie
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Allergan S.A. DE C.V..1 study
Something wrong with this grouping? Tell us on the AbbVie page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All AbbVie studies →
- Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)CompletedNCT01737853
Sponsor listed in the registry: Allergan S.A. DE C.V.. · First submitted before Allergan S.A. DE C.V.. became part of AbbVie